VYNE Therapeutics Statistics
Total Valuation
VYNE has a market cap or net worth of $41.60 million. The enterprise value is -$28.46 million.
Important Dates
The last earnings date was Thursday, November 7, 2024, before market open.
Earnings Date | Nov 7, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
VYNE has 14.75 million shares outstanding. The number of shares has increased by 1,119.93% in one year.
Current Share Class | 14.75M |
Shares Outstanding | 14.75M |
Shares Change (YoY) | +1,119.93% |
Shares Change (QoQ) | +0.00% |
Owned by Insiders (%) | 1.72% |
Owned by Institutions (%) | 32.31% |
Float | 10.80M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 227.46 |
Forward PS | 203.92 |
PB Ratio | 0.65 |
P/TBV Ratio | 0.65 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.81, with a Debt / Equity ratio of 0.00.
Current Ratio | 5.81 |
Quick Ratio | 5.54 |
Debt / Equity | 0.00 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -90.47% and return on invested capital (ROIC) is -62.69%.
Return on Equity (ROE) | -90.47% |
Return on Assets (ROA) | -49.36% |
Return on Capital (ROIC) | -62.69% |
Revenue Per Employee | $49,300 |
Profits Per Employee | -$3.41M |
Employee Count | 10 |
Asset Turnover | 0.01 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -27.88% in the last 52 weeks. The beta is 1.35, so VYNE's price volatility has been higher than the market average.
Beta (5Y) | 1.35 |
52-Week Price Change | -27.88% |
50-Day Moving Average | 2.33 |
200-Day Moving Average | 2.26 |
Relative Strength Index (RSI) | 56.07 |
Average Volume (20 Days) | 122,288 |
Short Selling Information
The latest short interest is 82,561, so 0.56% of the outstanding shares have been sold short.
Short Interest | 82,561 |
Short Previous Month | 49,968 |
Short % of Shares Out | 0.56% |
Short % of Float | 0.76% |
Short Ratio (days to cover) | 1.23 |
Income Statement
In the last 12 months, VYNE had revenue of $493,000 and -$34.15 million in losses. Loss per share was -$0.86.
Revenue | 493,000 |
Gross Profit | 493,000 |
Operating Income | -37.70M |
Pretax Income | -29.08M |
Net Income | -34.15M |
EBITDA | n/a |
EBIT | -37.70M |
Loss Per Share | -$0.86 |
Full Income Statement Balance Sheet
The company has $70.19 million in cash and $123,000 in debt, giving a net cash position of $70.06 million or $4.75 per share.
Cash & Cash Equivalents | 70.19M |
Total Debt | 123,000 |
Net Cash | 70.06M |
Net Cash Per Share | $4.75 |
Equity (Book Value) | 63.54M |
Book Value Per Share | 4.31 |
Working Capital | 60.87M |
Full Balance Sheet Cash Flow
Operating Cash Flow | -30.11M |
Capital Expenditures | n/a |
Free Cash Flow | -30.11M |
FCF Per Share | -$2.04 |
Full Cash Flow Statement Margins
Gross Margin | 100.00% |
Operating Margin | -7,646.86% |
Pretax Margin | -6,885.40% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | -6,582.74% |
Dividends & Yields
VYNE does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -1,119.93% |
Shareholder Yield | -1,119.93% |
Earnings Yield | -82.09% |
FCF Yield | -72.38% |
Analyst Forecast
The average price target for VYNE is $6.88, which is 143.97% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $6.88 |
Price Target Difference | 143.97% |
Analyst Consensus | Strong Buy |
Analyst Count | 2 |
Revenue Growth Forecast (5Y) | 167.61% |
EPS Growth Forecast (5Y) | -44.02% |
Stock Forecasts Stock Splits
The last stock split was on February 13, 2023. It was a reverse split with a ratio of 0.0555556:1.
Last Split Date | Feb 13, 2023 |
Split Type | Reverse |
Split Ratio | 0.0555556:1 |
Scores
VYNE has an Altman Z-Score of -12.44 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -12.44 |
Piotroski F-Score | 2 |